| Income Statement | 2026-06-30 | |||
|---|---|---|---|---|
| Revenue | 7,899,249 | |||
| Cost of goods sold | 3,058,588 | |||
| Gross profit | 4,840,661 | |||
| Sales and marketing | 5,321,885 | |||
| General and administrative | 6,496,530 | |||
| Research and development | 733,616 | |||
| Depreciation and amortization | 689,317 | |||
| Total operating expenses | 13,241,348 | |||
| (loss) income from operations | -8,400,687 | |||
| Interest income, net | 23,362 | |||
| Other (expense) income | -594,035 | |||
| Other (expense) income, net | -570,673 | |||
| Total (loss) income from operations before income taxes | -8,971,360 | |||
| Income tax expense | 0 | |||
| Net (loss) income | -8,971,360 | |||
| Basic EPS | -0.52 | |||
| Diluted EPS | -0.52 | |||
| Basic Average Shares | 17,327,652 | |||
| Diluted Average Shares | 17,327,652 | |||
BioStem Technologies, Inc. (BSEM)
BioStem Technologies, Inc. (BSEM)